Seqera

Seqera

Orchestrates Nextflow pipelines for genomics

Overview

Seqera Labs provides software to orchestrate data analysis pipelines in genomics and life sciences. Built on Nextflow, Seqera Tower adds enterprise features for collaboration, monitoring, and deploying pipelines at scale on premises or in the cloud. It differentiates by offering an enterprise-grade runtime layer on top of the open-source Nextflow core, focusing on governance, scalability, and collaboration for pharma, biotech, and genomics teams. The goal is to help researchers accelerate genomic data analysis and drug discovery, enabling faster public health responses and more efficient scientific workflows across large organizations.

Significant Headcount Growth

About Seqera

Simplify's Rating
Why Seqera is rated
C+
Rated C on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series A

Total Funding

$29.8M

Headquarters

Barcelona, Spain

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Raised $26M Series B in May 2025 led by Addition for North American expansion.
  • Partners with Genomics England since May 2023 to scale 100,000 Genomes Project analysis.
  • Supplies HPC to Alinghi Red Bull Racing for 37th America's Cup since October 2023.

What critics are saying

  • AWS Genomics CLI natively supports Nextflow since June 2025, commoditizing Tower demand.
  • nf-core forks erode enterprise value by replicating Tower features for free.
  • Seven Bridges acquires AI startups, leapfrogging Seqera's capabilities and stealing AstraZeneca.

What makes Seqera unique

  • Seqera Tower centralizes Nextflow pipelines with collaboration and monitoring for life sciences.
  • Open-source Nextflow, created by Di Tommaso in 2013, powers Seqera's bioinformatics orchestration.
  • Acquired Tinybio to integrate AI-powered bioinformatics via natural language processing.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$29.8M

Above

Industry Average

Funded Over

3 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Above Average

Industry standards

$15M
$8.2M
Discord
$15M
Canva
$24.2M
Seqera
$30M
Kalshi

Benefits

Health Insurance

Private health insurance

Wellness Program

Mental Health Support

Home Office Stipend

Learning and development budget per year (1,000 USD)

Unlimited Paid Time Off

Flexible Work Hours

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

4%

2 year growth

7%
HIT Consultant
Aug 6th, 2024
Seqera Acquires Tinybio to Democratize Access to AI-Powered Bioinformatics

Seqera acquires Tinybio to democratize access to ai-powered bioinformatics.

HIT Consultant
Aug 6th, 2024
Seqera Acquires Tinybio for AI Bioinformatics

Seqera has acquired Tinybio, a tech-bio startup specializing in AI-powered bioinformatics tools, to enhance its scientific data analysis platform. The acquisition aims to democratize access to advanced bioinformatics through natural language processing and user-friendly interfaces. Tinybio’s founders, CEO Sasha Dagayev and CTO Vishal Patel, will collaborate with Seqera to advance open-source software and scientific progress. Financial details were not disclosed.

HPCwire
Dec 11th, 2023
Opportunity | Using AWS Batch to Deliver HPC to Global Customers for Seqera

In 2020, Seqera launched Seqera Platform (formerly Nextflow Tower), a centralized command post for Nextflow pipelines.

GNT Média
Oct 20th, 2023
Seqera Sets Sail With Alinghi Red Bull Racing as Official High Performance Computing Supplier

BARCELONA, Spain, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Seqera, the leading software provider for complex data analysis in the life sciences space, has been confirmed as the official High Performance Computing Supplier for Alinghi Red Bull Racing at the 37 America's Cup.

PharmiWeb.com
Jun 14th, 2023
Researchers Tackling Biggest Health Crises Say Open-Source Collaboration Is Now ‘Fundamental’

Researchers tackling biggest health crises say open-source collaboration is now ‘fundamental’75% of 500 global researchers are collaborating on health research projects including oncology and infectious disease monitoringLONDON, June 2023: As the UK Health Security Agency announces a plan for a “genomics transformation”, new data has revealed that nearly three quarters (72%) of research scientists believe open-source collaboration and workflow management is now “fundamental” to the work they do.The data published by Seqera Labs, the leading provider of secure data orchestration software, brings together the views of 500 researchers and scientists who use open-source scientific workflow platforms for their work. Such systems are used by researchers to standardize the way data is analysed, reduce duplication and provide the infrastructure for high level projects both within their organizations and externally in genomics, metagenomics, and transcriptomics.The study found that open-source workflow platforms are currently being utilized across all continents, with two fifths (41%) noting the value for cross-organization collaboration and a third (32%) highlighting the benefits in international collaboration more broadly. With global scientific knowledge and resources spread across the world, over two fifths (41%) said community adoption of a workflow system was very important to the future of their research. One in three (34%) noted the financial savings that open-source scientific workflows had brought them as significant for their research.Harshil Patel, Head of Scientific Development, Seqera Labs comments: “Significant improvements in the ability for data orchestration tools to manage and organize large volumes of data empowered nations to monitor the spread of Covid-19 and continue to operate at the forefront of the world’s defences against the likes of influenza, RSV and Avian Flu. These tools are operating on the precipice of scientific discovery and are acting as the first line of defence against pandemic threats. Improved efficiency and scalability of research infrastructure is now fundamental for ongoing scientific research and future breakthroughs as they are no longer impeded by cost or capacity restraints when it comes to the pipelines used.”As breakthroughs in personalized medicines and gene therapies create the prospect of ever-more sophisticated treatments for patients, the scientific infrastructure behind such research is improving alongside it

Recently Posted Jobs

Sign up to get curated job recommendations

Seqera is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →